Sangamo Therapeutics, Inc. has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware, resulting in the appointment of an examiner to investigate claims by creditors.
Sangamo Therapeutics, Inc. has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware, resulting in the appointment of an examiner to investigate claims by creditors.